The infant’s mother was a 35-year-old gravida 1, para 0 woman with a prenatal course significant for insulin-controlled gestational diabetes and noninvasive prenatal testing that was high risk for trisomy 13, with the performing laboratory specifying a positive predictive value of 29.5%. The family met with a genetic counselor to discuss the expected outcomes for infants with trisomy 13. The family opted not to pursue confirmatory testing via amniocentesis because the result would not affect their desire to continue the pregnancy and provide full resuscitation. Fetal echocardiography results were notable for a small-to-moderate membranous ventricular septal defect (VSD); otherwise, no anomalies were identified on prenatal ultrasonography. Fetal growth and amniotic fluid volumes were appropriate; however, fetal movement was noted to be decreased on the biophysical profile at 37 weeks’ gestation (6/8 for lack of movement).

The infant was born through meconium-stained amniotic fluid via spontaneous vaginal delivery at 39 weeks...

You do not currently have access to this content.